Navigation Links
Pharmacopeia to Present at BIO CEO & Investor Conference 2008
Date:2/4/2008

PRINCETON, N.J., Feb. 4 /PRNewswire-FirstCall/ -- Pharmacopeia (Nasdaq: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, today announced that Dr. Leslie J. Browne, President and Chief Executive Officer, will deliver a corporate presentation at the BIO CEO & Investor Conference 2008. The conference will be held February 11-13, 2008, at The Waldorf-Astoria Hotel in New York City.

Dr. Browne's presentation will take place at 2:00 p.m. EST on Tuesday, February 12th. The presentation will include an overview of the company's drug development pipeline, including an update on its internal clinical programs, PS433540 (DARA), which is progressing in Phase 2, and PS178990 (SARM), which is currently in Phase 1. A live webcast and 90-day archive of the presentation can be accessed at http://www.pharmacopeia.com.

ABOUT PHARMACOPEIA

Pharmacopeia is a clinical development stage biopharmaceutical company dedicated to discovering and developing novel small molecule therapeutics to address significant medical needs. The company has a broad portfolio of clinical and preclinical candidates under development internally or by partners including seven clinical compounds in Phase 2 or Phase 1 development addressing multiple indications including hypertension, diabetic nephropathy, muscle wasting, inflammation and respiratory disease. The company is leveraging its fully integrated drug discovery platform to sustain the growth of its development pipeline. Pharmacopeia has established strategic agreements with major pharmaceutical and biotechnology companies, including Bristol-Myers Squibb, Celgene, Cephalon, GlaxoSmithKline, Schering-Plough, and Wyeth Pharmaceuticals. For more information please visit the company's website at http://www.pharmacopeia.com.

Contact:

Amy P. Sharpless

Corpora
'/>"/>

SOURCE Pharmacopeia
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmacopeia Announces Additional Positive Findings from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
2. Pharmacopeia Announces Third Quarter 2007 Financial Results
3. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
4. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
5. Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA)
6. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
7. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
8. NanoBio Corporation Presents Preclinical and Interim Clinical Data on Topical Treatments for Herpes Labialis and Onychomycosis at AAD 2008
9. ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference
10. Genaera Corporation Presents Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at Keystone Symposia
11. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... DIEGO , Dec. 23, 2014 ResMed (NYSE: ... significant patent infringement action against Chinese medical device manufacturer BMC ... (ITC) ruled today that BMC,s masks listed below infringe ResMed,s ... or selling these masks in the United States ... iVolve N2 nasal mask , Willow nasal pillows mask ...
(Date:12/24/2014)... , Dec. 23, 2014   Assurex Health, ... decision support to healthcare providers for behavioral health ... has secured $30 million in equity financing from ... C. Drosos , President and Chief Executive Officer. ... adoption and development of Assurex Health,s GeneSight ...
(Date:12/24/2014)... , Dec. 23, 2014 Tianyin Pharmaceutical ... that specializes in patented biopharmaceutical, modernized traditional Chinese ... (API) today announced that the Company achieved the ... Manufacturing Practice (GMP) certificate of TPI,s Qionglai Facility ... (CFDA). The public notice period is a significant ...
Breaking Medicine Technology:ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3
... 5, 2011 Reportlinker.com announces that ... available in its catalogue: ... Assessments of Leading Suppliers ... This report provides industry executives with ...
... 5, 2011 Reportlinker.com announces that a new ... China In Vitro Diagnostics ... http://www.reportlinker.com/p0240263/China-In-Vitro-Diagnostics-Market-Outlook-to-2016.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic China In Vitro ... Summary GlobalData,s new report, "China ...
Cached Medicine Technology:Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers 2Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers 3Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers 4Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers 5Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers 6Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers 7China In Vitro Diagnostics Market Outlook to 2016 2China In Vitro Diagnostics Market Outlook to 2016 3China In Vitro Diagnostics Market Outlook to 2016 4China In Vitro Diagnostics Market Outlook to 2016 5China In Vitro Diagnostics Market Outlook to 2016 6China In Vitro Diagnostics Market Outlook to 2016 7China In Vitro Diagnostics Market Outlook to 2016 8China In Vitro Diagnostics Market Outlook to 2016 9China In Vitro Diagnostics Market Outlook to 2016 10China In Vitro Diagnostics Market Outlook to 2016 11China In Vitro Diagnostics Market Outlook to 2016 12China In Vitro Diagnostics Market Outlook to 2016 13China In Vitro Diagnostics Market Outlook to 2016 14China In Vitro Diagnostics Market Outlook to 2016 15China In Vitro Diagnostics Market Outlook to 2016 16
(Date:12/24/2014)... Oregon (PRWEB) December 24, 2014 ... Rehab sat down with Derek Fenwick, PT, MBA, ... changes that will stem from the passing of the ... (IMPACT Act). In this taping of the Infinicast, ... title XVIII of the Social Security Act to standardize ...
(Date:12/24/2014)... Dec. 24, 2014 (HealthDay News) -- A new, injectable ... and Drug Administration. The agency on Tuesday approved ... those who are overweight and have at least one ... 2 diabetes or high cholesterol. Patients taking the ... low-calorie diet and exercise regularly, the FDA noted. ...
(Date:12/24/2014)... HealthDay Reporter TUESDAY, Dec. ... Diabetes Association (ADA) call for giving the cholesterol-lowering drugs known ... heart disease. These new standards bring the association in ... Association, which also recommend giving low- or high-dose statins to ... diabetes. "We agree that the decision to start a ...
(Date:12/24/2014)... 24, 2014 The 2014 Market ... professional and in-depth research report on COC industry. ... basic information, including its definition, classification, application, industry ... etc. This report also presents product specification, manufacturing ... separated by regions, technology and applications. Analysis also ...
(Date:12/24/2014)... Dental implants benefit millions of individuals ... They offer the strongest and most secure hold for ... of tooth replacement. They will never slip out of ... for support, and they prevent the jaw from shrinking ... they are not suitable candidates for dental implants because ...
Breaking Medicine News(10 mins):Health News:Latest Episode of Infinicast Features Infinity Rehab President Discussing IMPACT Act of 2014 and Changes for Post-Acute Therapy Providers in 2015 2Health News:FDA Approves New Weight-Loss Drug 2Health News:FDA Approves New Weight-Loss Drug 3Health News:Nearly All Diabetics Should Be on Cholesterol-Lowering Drugs: Experts 2Health News:Nearly All Diabetics Should Be on Cholesterol-Lowering Drugs: Experts 3Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 2Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 3Health News:Innovative Dental Implant Procedure to Gain Momentum in the New Year 2
... at Galveston researchers have achieved promising results with a ... common cause of infant hospitalization in the United States. ... therapy for RSV, the scientists tested two types of ... that RSV uses to replicate, or copy itself, within ...
... in New Public Service Advertisement ... ... and Brittany Lietz wanted was a dark tan. They thought it made,them ... they,would be battling melanoma, the deadliest form of skin cancer. Now Meghan,24, ...
... Needed to Prepare,for Future Disasters Especially on the Eve ... American Red Cross,today announced that it has met the ... its Disaster Relief Fund are still,needed to ensure it ... of hurricane season starting in less than a month., ...
... With spring in the air, most of,us ... that warm weather,brings -- flip flops, shorts, sunglasses, ... in sunscreen protection have become more,plentiful than ever, ... from ultraviolet (UV) light. Fortunately,dermatologists can help you ...
... License for Pulse!! Virtual Learning Platform for ... Clinical Skills and Decision Making Training, ... of,game-based technology solutions for training, experimentation and,decision-making analysis, has ... for the exclusive, worldwide rights to Pulse!! the,Virtual Clinical ...
... Floral Bouquet Purchased at, http://www.proflowers.com/CHF Will ... Ill., May 5 The Children,s Heart,Foundation today ... fresh flower marketplace -- just in time for ... http://www.proflowers.com/CHF and choose,from a variety of ...
Cached Medicine News:Health News:New agent strikes at respiratory syncytial virus replication 2Health News:Indoor Tanning is Not as Safe as You Think. In Fact, It's Totally Out: 2Health News:Indoor Tanning is Not as Safe as You Think. In Fact, It's Totally Out: 3Health News:Indoor Tanning is Not as Safe as You Think. In Fact, It's Totally Out: 4Health News:Generous Donors Allow Red Cross to Respond Swiftly and Effectively to Southeastern Virginia Tornadoes 2Health News:Generous Donors Allow Red Cross to Respond Swiftly and Effectively to Southeastern Virginia Tornadoes 3Health News:Recent Advances Make Sunscreen More Effective and Easier to Use 2Health News:Recent Advances Make Sunscreen More Effective and Easier to Use 3Health News:Recent Advances Make Sunscreen More Effective and Easier to Use 4Health News:Recent Advances Make Sunscreen More Effective and Easier to Use 5Health News:Recent Advances Make Sunscreen More Effective and Easier to Use 6Health News:Game-Based Technology to Meet Demand for Improved Medical Teaching and Training 2Health News:Game-Based Technology to Meet Demand for Improved Medical Teaching and Training 3Health News:The Children's Heart Foundation Teams Up With ProFlowers(R) to Raise Awareness and Funding for the Leading Birth Defect in America 2Health News:The Children's Heart Foundation Teams Up With ProFlowers(R) to Raise Awareness and Funding for the Leading Birth Defect in America 3
... the first intra-operative fluorescent imaging system ... the location of the coronary arteries ... coronary artery bypass procedures. ,The patented ... to view, record, replay, print, and ...
... When myocardial infarction is ... TROPT sensitive rapid assay allows ... marker troponin T from a ... qualitative result is available within ...
The Polygraf ID multi-parametric recorder works with POLYGRAM NET analysis software to create a unique interface that combines web-style navigation, graphical presentation and intuitive design to del...
... The White Sun light source offers the industry ... Kelvin color temperature at a lower price. A ... White Sun to be used with Olympus, Storz, ... light output LED and re-settable bulb timer. The ...
Medicine Products: